Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-24-019902
Filing Date
2024-07-22
Accepted
2024-07-22 20:01:51
Documents
2
Period of Report
2024-07-19

Document Format Files

Seq Description Document Type Size
1 form3-07232024_120747.html 3  
1 form3-07232024_120747.xml 3 1687
2 ex24-07232024_120747.htm EX-24 4802
  Complete submission text file 0001415889-24-019902.txt   7962
Mailing Address C/O SAETTLE GENETICS INC 21823 30TH DRIVE SE BOTHELL WA 98021
Business Address
DOBMEIER ERIC (Reporting) CIK: 0001202785 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40475 | Film No.: 241132675

Mailing Address 10955 VISTA SORRENTO PARKWAY SUITE 200 SAN DIEGO CA 92130
Business Address 10955 VISTA SORRENTO PARKWAY SUITE 200 SAN DIEGO CA 92130 (858) 751-4493
Janux Therapeutics, Inc. (Issuer) CIK: 0001817713 (see all company filings)

EIN.: 822289112 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)